Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OsrHSA vs human albumin in cirrhosis with hypoalbuminemia
CTR20230244Phase 3Completed
- Sponsor
- Healthgen Biotech
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of albumin (human) in Cirrhosis, hypoalbuminemia, sponsored by Healthgen Biotech. Started Jan 2023; status: completed.
02
Drugs
albumin (human)
03
Conditions
Cirrhosishypoalbuminemia
Beyond the preview
Go deeper on CTR20230244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230244.